FindTrial
Sign In

Observational study of an uncommon inflammatory condition of the breast

Granulomatous mastitis: prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019776
Enrollment
33
Registered
2019-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N610- Mastitis without abscess

Interventions

None listed

Sponsors

Department of General Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients coming to Kasturba Hospital, Manipal with suspicion of granulomatous mastitis between June 2019 to August 2020 which is confirmed on HPE

Exclusion criteria

Exclusion criteria: Non granulomatous mastitis and tubercular mastitis proved by HPE, culture or PCR.

Design outcomes

Primary

MeasureTime frame
Clinical response rate: (Complete resolution / partial resolution / no response), recurrence.Timepoint: 6 months from date of completion of treatment.—

Secondary

MeasureTime frame
Adverse events associated with steroids Cosmesis of breast : a) subjective by the patient and b) objective by surgeonTimepoint: 6 months from date of completion of treatment.—

Countries

India

Contacts

Public ContactDr Badareesh L

Kasturba Medical College, Manipal Academy of Higher Education, Manipal

stanley.mathew@manipal.edu9844409900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026